Geulah Livshits
Stock Analyst at Chardan Capital
(3.7)
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
KRYS Krystal Biotech | Maintains: Buy | 219 216 | 137.46 | 57.14% | 13 | Aug 22, 2025 | |
RCKT Rocket Pharmaceutica... | Maintains: Buy | 11 11 | 3.18 | 245.91% | 21 | Aug 20, 2025 | |
LXEO Lexeo Therapeutics | Maintains: Buy | 20 15 | 5.2 | 188.46% | 10 | Aug 15, 2025 | |
MGX Metagenomi | Maintains: Buy | 12 11 | 1.84 | 497.83% | 7 | Aug 15, 2025 | |
PVLA Palvella Therapeutic... | Maintains: Strong Buy | 50 60 | 59.73 | 0.45% | 2 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 13 13 | 8.14 | 59.71% | 13 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 15 15 | 5.24 | 186.26% | 8 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 9 10 | 3.25 | 207.69% | 14 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 25 25 | 6.94 | 260.23% | 12 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 68 60 | 11.29 | 431.44% | 15 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 12 10 | 3.89 | 157.07% | 6 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 12 12 | 1.3 | 823.08% | 10 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 25 20 | 2.38 | 740.34% | 14 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 9 9 | 1.3 | 592.31% | 12 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 82 82 | 51.81 | 58.27% | 15 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 120 120 | 7.05 | 1602.13% | 5 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 7 6 | 0.51 | 1076.47% | 6 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 3 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 10 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 11 6 | 1.48 | 305.41% | 5 | Apr 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 41 41 | 7.49 | 447.4% | 4 | Aug 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 28 25 | 5.81 | 330.29% | 2 | Mar 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 12 | 1.74 | 589.66% | 4 | Mar 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 30 25 | 24.98 | 0.08% | 4 | Mar 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 191 208 | 24.31 | 755.61% | 7 | Jan 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 160 40 | n/a | n/a | 3 | Dec 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 15 16 | 1.23 | 1200.81% | 4 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 4 3 | 7.89 | -68.31% | 5 | Aug 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 450 270 | 0.93 | 28932.26% | 2 | Feb 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 100 90 | 9.57 | 840.44% | 1 | Nov 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 6 4 | 4.16 | -3.85% | 3 | Nov 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 20 | 3.2 | 525% | 1 | Oct 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 660 600 | n/a | n/a | 2 | Aug 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 50 30 | 3.31 | 806.34% | 1 | Jul 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 18 | 9 | 100% | 1 | Oct 27, 2020 |